Nomad Foods Q4 2025 Earnings Report Analysis
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Mar 01 2026
0mins
Should l Buy NOMD?
Source: Yahoo Finance
- Disappointing Earnings: Nomad Foods reported a 9.76% year-over-year revenue increase to $912.43 million in Q4 2025, yet missed expectations by $2.95 million, resulting in an over 11% decline in share price.
- Earnings Forecast Downgrade: The EPS of $0.51 fell short of expectations by $0.01, indicating the company's struggle with supply chain inflation without raising consumer prices, leading to a 2% decline in annual sales.
- Pessimistic Future Outlook: Management anticipates organic sales to drop further by 2% to 5% in 2026, with adjusted EPS expected to decline between 4% and 13%, highlighting the challenges under new CEO Dominic Brisby's leadership during a transformative year.
- Analyst Rating Adjustments: Despite Jefferies and Deutsche Bank lowering their price targets to $16 and $15 respectively, both maintained a Buy rating, reflecting confidence in the company's long-term potential despite current challenges.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy NOMD?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on NOMD
Wall Street analysts forecast NOMD stock price to rise
4 Analyst Rating
4 Buy
0 Hold
0 Sell
Strong Buy
Current: 10.140
Low
15.00
Averages
15.75
High
17.00
Current: 10.140
Low
15.00
Averages
15.75
High
17.00
About NOMD
Nomad Foods Limited is a frozen food company. The Company's portfolio of brands includes Birds Eye, Findus, iglo, Ledo, and Frikom. Its portfolio of food brands within the frozen category including fish, vegetables, poultry, meals, pizza, and ice cream. The products are sold primarily through grocery retailers under the Birds Eye brand in the United Kingdom and Ireland, Findus in Italy, France, Spain, Sweden, Switzerland and Norway, iglo in Germany and other continental markets, La Cocinera in Spain, Ledo in south-eastern Europe and Frikom in Serbia and North Macedonia. Its product offerings include frozen fish products, such as fish fingers, coated fish, natural fish; ready to cook vegetable products, such as peas and spinach; meals, such as ready to cook noodles, lasagna, pancakes and other ready-made meals; poultry, such as frozen poultry and meat products, such as nuggets, grills, burgers, and others. It manufactures, sells and distributes products in over 22 European markets.
About the author

Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
- Earnings Beat: Nomad Foods reported a Q1 non-GAAP EPS of €0.23, exceeding expectations by €0.01, indicating resilience in profitability despite challenging market conditions.
- Revenue Decline: The company generated €715M in revenue, a 5.9% year-over-year decline, missing estimates by €98.14M, reflecting the negative impact of macroeconomic pressures on sales and potentially influencing future market strategies.
- Gross Margin Contraction: Gross margin contracted by 210 basis points, indicating rising costs and intensified competition affecting profitability, which may compel the company to reassess its pricing strategy to maintain profit levels.
- Profit Decrease: Net profit fell 12% to €29 million, with adjusted EBITDA down 22.9% to €93 million, highlighting the challenges faced by the company in the current economic environment, necessitating measures to improve operational efficiency and cost control.
See More
- Earnings Announcement: Nomad Foods is set to release its Q1 2023 earnings report on May 7 before market open, with a consensus EPS estimate of $0.22, reflecting a significant 37.1% year-over-year decline, indicating increasing pressure on profitability.
- Revenue Expectations: The revenue estimate for Q1 stands at $813.14 million, representing a 7.0% year-over-year growth, which, while modest, suggests some resilience in the market that may provide short-term confidence for investors.
- Historical Performance Review: Over the past two years, Nomad Foods has beaten EPS estimates 75% of the time and revenue estimates 88% of the time, indicating a degree of stability in financial performance despite current macroeconomic challenges.
- Estimate Revision Trends: In the last three months, there have been no upward revisions to EPS estimates, with five downward adjustments, and similarly, revenue estimates have seen no upward revisions and four downward adjustments, reflecting a cautious market sentiment regarding the company's future performance.
See More
- Yield Comparison: Consumer staples stocks are yielding between 5.2% and 11.3%, indicating a significant appeal for certain stocks amidst market turmoil, especially when compared to the average yield across the consumer staples sector, which enhances their return potential.
- Kimberly-Clark's Acquisition Plan: Kimberly-Clark (KMB) is set to acquire Kenvue for $48.7 billion, which is expected to make it the second-largest health and wellness company globally; despite potential dilution for existing shareholders, this presents an opportunity to invest at a 5.2% yield.
- Nomad Foods' Restructuring: Nomad Foods (NOMD) is expected to undergo restructuring in 2026 after facing volume declines and rising costs, yet its 7% yield remains attractive, demonstrating the company's determination to seek growth in adversity.
- Flowers Foods' High Risk: Flowers Foods (FLO) offers a high yield of 11.3%, but with significant debt and declining profits, future dividends may be at risk, prompting investors to closely monitor the upcoming annual performance announcement to assess the company's financial health.
See More
- Earnings Report Schedule: Nomad Foods has announced it will report its Q1 2026 results on May 7, 2026, providing a press release and supplemental materials to ensure timely access to key information for investors.
- Management Discussion: Prior to the earnings release, Nomad Foods management will host a pre-recorded discussion, followed by a live Q&A session at 8:30 AM Eastern Daylight Time, enhancing engagement with investors.
- Participation Details: North American listeners can dial +1-877-451-6152 to join the call, while international listeners can reach +1-201-389-0879, ensuring global investor participation in the discussion.
- Replay Availability: Following the conference call, Nomad Foods will offer a replay on its website for two weeks, with North American listeners using +1-844-512-2921 and international listeners using +1-412-317-6671, allowing those unable to attend live to access the information.
See More
- Overview of Oversold Stocks: According to Benzinga Pro, major players in the consumer staples sector, including Nomad Foods Ltd, Vital Farms, Inc., and MGP Ingredients Inc, have relative strength indices (RSI) near or below 30, indicating these stocks are significantly undervalued and may present buying opportunities for investors.
- RSI Indicator Interpretation: The relative strength index (RSI) serves as a momentum indicator that compares a stock's strength on days when prices rise to its strength on days when prices fall, thereby assisting traders in better assessing short-term stock performance and informing their investment decisions.
- Market Opportunity Analysis: In the current market environment, oversold stocks are often viewed as potential investment opportunities, particularly in the consumer staples sector, where investors can capitalize on these undervalued companies to position themselves for future returns.
- Industry Comparison: Benzinga also provides scores for other stocks in the consumer staples sector, allowing investors to gain a more comprehensive understanding of market dynamics and optimize their portfolios to enhance return potential.
See More
- Disappointing Earnings: Nomad Foods reported a 9.76% year-over-year revenue increase to $912.43 million in Q4 2025, yet missed expectations by $2.95 million, resulting in an over 11% decline in share price.
- Earnings Forecast Downgrade: The EPS of $0.51 fell short of expectations by $0.01, indicating the company's struggle with supply chain inflation without raising consumer prices, leading to a 2% decline in annual sales.
- Pessimistic Future Outlook: Management anticipates organic sales to drop further by 2% to 5% in 2026, with adjusted EPS expected to decline between 4% and 13%, highlighting the challenges under new CEO Dominic Brisby's leadership during a transformative year.
- Analyst Rating Adjustments: Despite Jefferies and Deutsche Bank lowering their price targets to $16 and $15 respectively, both maintained a Buy rating, reflecting confidence in the company's long-term potential despite current challenges.
See More










